Eczematous plaques related to unfractionated and low-molecular-weight heparins: cross-reaction with danaparoid but not with desirudin.
Martin
L
L
Department of Dermatology, CHU Trousseau, Tours, France.
Machet
L
L
Gironet
N
N
Pouplard
C
C
Gruel
Y
Y
Vaillant
L
L
D000925:Anticoagulants / Q000009:adverse effects*; D002809:Chondroitin Sulfates / Q000009:adverse effects*; D003429:Cross Reactions; D003871:Dermatan Sulfate / Q000009:adverse effects*; D004338:Drug Combinations; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000209:etiology*; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects*; D006496:Heparinoids / Q000009:adverse effects*; D006497:Heparan Sulfate / Q000009:adverse effects*; D006629:Hirudins / Q000009:adverse effects / Q000031:analogs & derivatives; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced* / Q000175:diagnosis; D011994:Recombinant Proteins / Q000009:adverse effects; D012882:Skin Tests
D000925:Anticoagulants; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D004338:Drug Combinations; D006495:Heparin, Low-Molecular-Weight; D006496:Heparinoids; D006497:Heparan Sulfate; D006629:Hirudins; D011994:Recombinant Proteins; C035838:danaparoid; C060225:desirudin